Phosphorus homeostasis

Phosphorus homeostasis refers to the tightly regulated physiological process that maintains stable concentrations of inorganic phosphate (Pi) within the body. This equilibrium involves coordinated actions among several organs—primarily the kidneys, bones, intestines—and is governed by multiple hormones including parathyroid hormone (PTH), fibroblast growth factor 23 (FGF23), vitamin D metabolites like calcitriol (1alpha,25(OH)2D3), and co-factors such as Klotho protein. These regulators control intestinal absorption of dietary phosphate, renal reabsorption/excretion via sodium-dependent cotransporters like NPT2a/NPT2c/PiT1/PiT2, release from bone stores, and cellular uptake/release.\n\nDisorders in phosphorus homeostasis can lead to significant clinical consequences including chronic kidney disease-mineral and bone disorder (CKD-MBD), rickets/osteomalacia due to hypophosphatemia or excess FGF23 ("phosphatonins"), secondary hyperparathyroidism due to chronic hyperphosphatemia, tumor-induced osteomalacia mediated by overproduction of phosphaturic peptides like FGF7 or MEPE, among others.\n\nBecause "Phosphorus homeostasis" describes an integrated biological system rather than a discrete molecular target such as an enzyme or receptor protein, it is not considered a therapeutic target per se but rather an important physiological endpoint influenced by various drug targets within its regulatory network.

Other names

Phosphate homeostasisPi homeostasisRegulation of phosphate metabolismPhosphorus balance

Mechanisms relate to modulation of the hormones and transporters controlling phosphate levels, such as: - Inhibition of intestinal phosphate absorption - Modulation of parathyroid hormone secretion/action - Alteration of vitamin D metabolism